Company news: Orexigen Therapeutics
Orexigen Therapeutics, whose experimental obesity pill Contrave was rejected by the FDA in January, said it's laying off 23 employees, ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.